Physician profile
Jodi Maxfield
NPI 1922023894
$616.57
in general payments reported to CMS, 2019-2025
13 companies · $16.05 in 2025
The $16.05 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $400 · 2020: $28.83 · 2021: $68.52 · 2022: $12.50 · 2023: $72.99 · 2024: $17.32 · 2025: $16.05.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $106.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $106.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $222.87 | 2019-2021 | |
| Amgen INC. | $55.65 | 2019 | |
| Organon LLC | $54.26 | 2021-2025 | Nexplanon |
| Bayer Healthcare Pharmaceuticals INC. | $50.26 | 2019-2023 | |
| Amag Pharmaceuticals, INC. | $49.52 | 2019 | |
| Merck Sharp & Dohme LLC | $37.64 | 2019-2020 | |
| Hologic Sales and Service, LLC | $35.96 | 2019-2022 | |
| Astellas Pharma US INC | $31.78 | 2023 | Veozah |
| Myovant Sciences INC. | $22.86 | 2021 | |
| Minerva Surgical, INC | $17.32 | 2024 | |
| Avion Pharmaceuticals | $14.10 | 2019 | |
| Coopersurgical, INC. | $12.82 | 2019 | |
| Allergan, INC. | $11.53 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jodi Maxfield listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.